Dashboard
Manage Tickers

CICigna Group

NYSE cigna.com


$ 333.30 $ -0.86 (-0.26 %)    

Friday, 14-Jun-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 333.29
$ 333.91
$ 0.00 x 0
$ 0.00 x 0
$ 328.75 - $ 333.91
$ 251.86 - $ 364.21
907,518
na
94.68B
$ 0.91
$ 26.15
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Medicare Star Rankings Revision Could Resu...
06/13/2024 18:53:18

https://www.wsj.com/health/healthcare/medicare-will-recalculate-quality-ratings-of-medicare-advantage-plans-eebee409?mod=latest...

cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-400-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/12/2024 16:22:41

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.

cigna-cfo-says-pre-pandemic-norms-had-more-seasonality-in-medical-care-ratio-and-thats-more-of-what-cos-expects-this-year
Cigna CFO Says Pre Pandemic Norms Had More...
06/11/2024 14:42:07

- Goldman Sachs Conf

cigna-cfo-says-over-the-next-decade-we-see-a-wave-of-drug-innovation-transpiring
Cigna CFO Says Over The Next Decade, We Se...
06/11/2024 14:21:57

- Goldman Sachs Conf

Core News & Articles
Cigna CFO Says Cumulative Effect Of Elevat...
06/11/2024 14:20:21

- Goldman Sachs Conf

cigna-cfo-says-co-expects-the-select-segment-to-be-where-it-gets-the-outsized-growth-in-the-cigna-healthcare-portfolio
Cigna CFO Says Co Expects The Select Segme...
06/11/2024 14:15:32

- Goldman Sachs Conf

cigna-cfo-says-co-expects-that-it-will-continue-to-see-elevated-inpatient-activity-throughout-the-entire-2024-calendar-year-outpatient-dynamic-was-impacted-by-change-healthcare-hacks-disruption-of-claims-in-q1
Cigna CFO Says Co Expects That It Will Con...
06/11/2024 14:10:35

- Goldman Sachs Conf

cigna-cfo-says-we-are-seeing-elevated-cost-trends-across-the-portfolio-but-in-line-with-what-we-had-priced-and-expected
Cigna CFO Says We Are Seeing Elevated Cost...
06/11/2024 14:06:48

- Goldman Sachs Conf

abbvies-arthritis-drug-humira-retains-market-dominance-despite-biosimilar-competition-challenges-biosimilar-industry-viability
AbbVie's Arthritis Drug Humira Retains Mar...
06/07/2024 14:39:05

Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the b...

cigna-expects-to-reaffirm-projected-fy24-consolidated-adjusted-eps-from-operations-of-at-least-2840-est-2829
Cigna Expects To Reaffirm Projected FY24 C...
06/06/2024 10:31:46

https://www.sec.gov/ix?doc=/Archives/edgar/data/1739940/000095015924000212/cigna8k.htm

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-3700-today
If You Invested $1000 In This Stock 10 Yea...
06/05/2024 15:30:16

jp-morgan-maintains-overweight-on-cigna-group-raises-price-target-to-435
JP Morgan Maintains Overweight on Cigna Gr...
05/30/2024 17:40:38

JP Morgan analyst Lisa Gill maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $432 to $435.

forecasting-the-future-12-analyst-projections-for-cigna-group
Forecasting The Future: 12 Analyst Project...
05/30/2024 15:00:31

baird-initiates-coverage-on-cigna-group-with-outperform-rating-announces-price-target-of-388
Baird Initiates Coverage On Cigna Group wi...
05/30/2024 09:48:09

Baird analyst Michael Ha initiates coverage on Cigna Group (NYSE:CI) with a Outperform rating and announces Price Target of ...

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-3800-today
If You Invested $1000 In This Stock 10 Yea...
05/16/2024 17:00:31

Core News & Articles
Michael Burry's Scion Asset Management 13F...
05/15/2024 16:47:43

https://13f.info/13f/000090514824001390-scion-asset-management-llc-q1-2024 

looking-into-cigna-groups-recent-short-interest
Looking Into Cigna Group's Recent Short In...
05/10/2024 19:30:21

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/03/2024 17:35:23

cantor-fitzgerald-maintains-overweight-on-cigna-group-raises-price-target-to-400
Cantor Fitzgerald Maintains Overweight on ...
05/03/2024 15:08:43

Cantor Fitzgerald analyst Sarah James maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $38...

oppenheimer-maintains-outperform-on-cigna-group-raises-price-target-to-400
Oppenheimer Maintains Outperform on Cigna ...
05/03/2024 13:02:58

Oppenheimer analyst Michael Wiederhorn maintains Cigna Group (NYSE:CI) with a Outperform and raises the price target from $3...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)